Watermelon consumption decreases risk factors of cardiovascular diseases: A systematic review and meta-analysis of randomized controlled trials
Authors' conclusion
The current findings provide promising evidence of the antihypertensive effect of watermelon.
Study context
- Population
- Randomized controlled trials (RCTs) of watermelon supplementation on CVD risk factors; Cochrane Library, ISI Web of Science, PubMed and Scopus up to March 20229 RCTs
- Comparison
- Watermelon supplementation vs control
- Outcome
- CVD risk factors
Methodological detailsrandom-effect model
- Random-effect model
Pooled result
As reported in the abstract
- Watermelon consumption significantly decreased systolic blood pressure (SBP), total cholesterol and low-density lipoprotein (LDL)
- Watermelon consumption led to a significant increase in fasting blood sugar (FBS)
- No significant difference in diastolic blood pressure (DBP), HR, BMI, body fat, serum arginine, insulin and CRP
Original publication
Watermelon consumption decreases risk factors of cardiovascular diseases: A systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract. Published 25 June 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →